Interleukin-3, Interleukin-5, and Cancer

作者: Arseniy E. Yuzhalin , Anton G. Kutikhin

DOI: 10.1016/B978-0-12-801121-8.00004-X

关键词:

摘要: Interleukin (IL)-3 and IL-5 are both regarded as hematopoietic cytokines, which means they provide positive negative regulation of differentiation, maturation, survival, proliferation, commitment, functional activation progenitor cells. This chapter briefly summarizes the existing knowledge on impact these cytokines malignancies. The will begin by giving definition family cytokines. following section points out molecular mechanisms that underlie link between activity interleukins features tumor development. Third, we shall discuss results preclinical studies role IL-3 cancer progression. Furthermore, evaluating prognostic considered well. Finally, shed light IL-3R its use a targeted therapy drug for

参考文章(148)
Bogna Okulczyk, Barbara Mroczko, Maciej Szmitkowski, Slawomir Ławicki, Małgorzata Czygier, Zdzisław Piotrowski, Selected hematopoietic cytokines in patients with colorectal cancer Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. ,vol. 15, pp. 416- ,(2003)
Li-Xin Shi, Lei Zhang, Sheng-Kun Sun, Xu Zhang, Serum cytokine profiling of prostate cancer and benign prostatic hyperplasia using recombinant antibody microarray National journal of andrology. ,vol. 16, pp. 584- ,(2010)
Shen-hua Xu, Jin-bo Xie, Xin Zhu, Li-sha Ying, Chi-hong Zhu, Clinicopathologic and prognostic significance of serum levels of cytokines in patients with advanced serous ovarian cancer prior to surgery Chinese Journal of Pathology. ,vol. 39, pp. 666- 670 ,(2010) , 10.3760/CMA.J.ISSN.0529-5807.2010.10.005
TR Ulich, J del Castillo, IK McNiece, SM Yin, B Irwin, K Busser, KZ Guo, Acute and subacute hematologic effects of multi-colony stimulating factor in combination with granulocyte colony-stimulating factor in vivo. Blood. ,vol. 75, pp. 48- 53 ,(1990) , 10.1182/BLOOD.V75.1.48.48
F Herrmann, M Brach, E Platzer, H Klein, R Mertelsmann, Effect of interleukin 3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts. Experimental Hematology. ,vol. 18, pp. 748- 753 ,(1990)
Richard B Pollard, D. A. Schmitt, Y. Hayashi, F. Suzuki, H. Sasaki, Inhibition of tumor growth by the intralesional administration of interleukin-3 into mice implanted with solid tumors. Anticancer Research. ,vol. 12, pp. 313- 315 ,(1992)
Fumiaki Isohashi, Xing Shuo, Masahiko Koizumi, Hideya Yamazaki, Takehiro Inoue, Hironobu Nakamura, Toshihiko Inoue, Eiichi Tanaka, Pelvic irradiation-induced eosinophilia is correlated to prognosis of cervical cancer patients and transient elevation of serum interleukin 5 level. Radiation Medicine. ,vol. 23, pp. 317- 321 ,(2005)
Masayoshi Kobune, Takuya Matsunaga, Yoshiro Niitsu, Rishu Takimoto, Yasushi Sato, Hiroyuki Kuroda, Tsutomu Sato, Shingo Tanaka, Junji Kato, Satoshi Iyama, Kazuyuki Murase, [Peripheral T-cell lymphoma presenting with eosinophilia due to interleukin-5 produced by lymphoma cells]. The Japanese journal of clinical hematology. ,vol. 47, pp. 1457- ,(2006)
K Geissler, C Peschel, D Niederwieser, H Strobl, J Goldschmitt, L Ohler, P Bettelheim, P Kahls, C Huber, K Lechner, P Hocker, K Kolbe, Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3 Blood. ,vol. 87, pp. 2732- 2739 ,(1996) , 10.1182/BLOOD.V87.7.2732.BLOODJOURNAL8772732
P. J. Quesenberry, H. E. McGrath, I. K. McNiece, Granulocyte colony stimulating factor augments in vitro megakaryocyte colony formation by interleukin-3 Experimental Hematology. ,vol. 16, pp. 807- 810 ,(1988)